the treatment brought about important plasma level reductions in cholesterol ( -35 % ) , triglycerides ( -56 % ) , vldl-cholesterol ( -63 % ) and vldl-triglycerides ( -59 % ) .
C0008377
cholesterol
C0023826
vldl-cholesterol